126 related articles for article (PubMed ID: 38145031)
21. Preservation surgery in patients with localized renal cell cancer--nephron sparing surgery.
Djozić J; Djozić S; Bogdanović J; Sekulić V; Djozić M; Vojinov S; Levakov I; Zivojinov S; Jeremić D; Marušić G; Djozić D
Acta Chir Iugosl; 2014; 61(1):45-9. PubMed ID: 25782225
[TBL] [Abstract][Full Text] [Related]
22. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.
Beck SD; Patel MI; Snyder ME; Kattan MW; Motzer RJ; Reuter VE; Russo P
Ann Surg Oncol; 2004 Jan; 11(1):71-7. PubMed ID: 14699037
[TBL] [Abstract][Full Text] [Related]
23. Benign adenomatous multicystic kidney tumor (Perlmann's tumor) and renal cortical carcinoma with adenomatous multicystic features: 12 cases.
Kirsh EJ; Straus FH; Goldfischer ER; Steinberg GD; Gerber GS
Urology; 1999 Jan; 53(1):65-70. PubMed ID: 9886590
[TBL] [Abstract][Full Text] [Related]
24. [Renal cell carcinoma in patients with end-stage renal disease: a clinicopathological analysis].
He B; Zhang W; Liu LN; Wang H; Zou YW; Jiang YX; Yu WJ; Shi HL; Liu Y; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):846-850. PubMed ID: 31775432
[No Abstract] [Full Text] [Related]
25. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
Belldegrun A; Tsui KH; deKernion JB; Smith RB
J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological features and surgical outcome of isolated metastasis of renal cell carcinoma.
Akatsu T; Shimazu M; Aiura K; Ito Y; Shinoda M; Kawachi S; Tanabe M; Ueda M; Kitajima M; Kitagawa Y
Hepatogastroenterology; 2007 Sep; 54(78):1836-40. PubMed ID: 18019729
[TBL] [Abstract][Full Text] [Related]
27. Oncological outcome of surgical treatment in 336 patients with renal cell carcinoma.
Zhang ZL; Li YH; Xiong YH; Hou GL; Yao K; Dong P; Liu ZW; Han H; Qin ZK; Zhou FJ
Chin J Cancer; 2010 Dec; 29(12):995-9. PubMed ID: 21114919
[TBL] [Abstract][Full Text] [Related]
28. Management of synchronous renal cell carcinoma and aortic disease.
Howe SF; Taylor RJ; Halloran BG; Smith S; Lynch TG; Baxter BT
Am J Surg; 1995 Aug; 170(2):231-4. PubMed ID: 7631938
[TBL] [Abstract][Full Text] [Related]
29. The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson EO; Lam TB; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Dabestani S; Bex A
Eur Urol Oncol; 2021 Jun; 4(3):473-482. PubMed ID: 33109495
[TBL] [Abstract][Full Text] [Related]
30. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.
Lau WK; Blute ML; Weaver AL; Torres VE; Zincke H
Mayo Clin Proc; 2000 Dec; 75(12):1236-42. PubMed ID: 11126830
[TBL] [Abstract][Full Text] [Related]
31. Racial Comparison of Patients Undergoing Minimally Invasive Partial Nephrectomy for Renal Masses at a Large Volume Tertiary Center.
Sands KG; Bhatt R; Vetter J; Paradis A; Chow AK; Bhayani S; Figenshau RS; Venkatesh R
J Endourol; 2021 Sep; 35(9):1365-1371. PubMed ID: 33730861
[No Abstract] [Full Text] [Related]
32. Renal oncocytoma: experience of Clinical Urology A, Urology Department, CHU Ibn Sina, Rabat, Morocco and literature review.
Benatiya MA; Rais G; Tahri M; Barki A; El sayegh H; Iken A; Nouini Y; Lachkar A; Benslimane L; Errihani H; Faik M
Pan Afr Med J; 2012; 12():84. PubMed ID: 23077705
[TBL] [Abstract][Full Text] [Related]
33. [The laparoscopic approach to renal tumors outcome of 121 laparoscopic radical and partial nephrectomy procedures].
Nadu A; Laufer M; Winkler H; Kleinmann N; Ramon J
Harefuah; 2005 Sep; 144(9):609-12, 679. PubMed ID: 16218528
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and outcomes in renal transplant recipients with renal cell carcinoma in the native kidney.
Sun IO; Ko YM; Kim EY; Park KS; Jung HS; Ko SH; Chung BH; Choi BS; Park CW; Kim YS; Yang CW
Korean J Intern Med; 2013 May; 28(3):347-51. PubMed ID: 23682229
[TBL] [Abstract][Full Text] [Related]
35. [Diagnosis and treatment of pancreatic metastasis from renal cell carcinoma].
Chi TY; Sang XT; Mao YL; Yang ZY; Lu X; Zhong SX; Huang JF
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):793-6. PubMed ID: 19173818
[TBL] [Abstract][Full Text] [Related]
36. Mortality Increases When Radical Nephrectomy is Delayed More Than 60 Days for T3 Renal Cell Carcinoma.
Zhao F; Liu X; Zhang C; Zhu H; Qi N
Technol Cancer Res Treat; 2021; 20():15330338211043963. PubMed ID: 34595976
[No Abstract] [Full Text] [Related]
37. Oncologic outcomes of nephron-sparing surgery in patients with T1 multifocal renal cell carcinoma.
Li G; Zhu D; Gao H; Chen H; Li Y; Niu Y
Clin Transl Oncol; 2019 Jun; 21(6):760-765. PubMed ID: 30443869
[TBL] [Abstract][Full Text] [Related]
38. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
[TBL] [Abstract][Full Text] [Related]
39. [Transabdominal radical nephrectomy for renal cell carcinoma: an experience on 155 patients].
Chen XF; Zhou FJ; Han H; Qin ZK; Liu ZW; Yu SL; Li YH; Wang H; Hou GL
Ai Zheng; 2007 May; 26(5):528-32. PubMed ID: 17672946
[TBL] [Abstract][Full Text] [Related]
40. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
